DE3789138T2 - Nukleotid-Sequenzen, die selektiv exprimiert sind in pre-B-Zellen und Sonden zu diesem Zweck. - Google Patents

Nukleotid-Sequenzen, die selektiv exprimiert sind in pre-B-Zellen und Sonden zu diesem Zweck.

Info

Publication number
DE3789138T2
DE3789138T2 DE19873789138 DE3789138T DE3789138T2 DE 3789138 T2 DE3789138 T2 DE 3789138T2 DE 19873789138 DE19873789138 DE 19873789138 DE 3789138 T DE3789138 T DE 3789138T DE 3789138 T2 DE3789138 T2 DE 3789138T2
Authority
DE
Germany
Prior art keywords
probes
cells
nucleotide sequences
selectively expressed
expressed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE19873789138
Other languages
English (en)
Other versions
DE3789138D1 (de
Inventor
Steven R Dr Bauer
Akira Dr Kudo
Georg Friedrich Prof Melchers
Nobuo Dr Sakaguchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868628433A external-priority patent/GB8628433D0/en
Priority claimed from GB878724100A external-priority patent/GB8724100D0/en
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of DE3789138D1 publication Critical patent/DE3789138D1/de
Application granted granted Critical
Publication of DE3789138T2 publication Critical patent/DE3789138T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE19873789138 1986-11-27 1987-11-27 Nukleotid-Sequenzen, die selektiv exprimiert sind in pre-B-Zellen und Sonden zu diesem Zweck. Expired - Fee Related DE3789138T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB868628433A GB8628433D0 (en) 1986-11-27 1986-11-27 Nucleotide sequence
GB878716497A GB8716497D0 (en) 1986-11-27 1987-07-14 Nucleotide sequences
GB878724100A GB8724100D0 (en) 1986-11-27 1987-10-14 Nucleotide sequences

Publications (2)

Publication Number Publication Date
DE3789138D1 DE3789138D1 (de) 1994-03-31
DE3789138T2 true DE3789138T2 (de) 1994-05-26

Family

ID=27263220

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19873789138 Expired - Fee Related DE3789138T2 (de) 1986-11-27 1987-11-27 Nukleotid-Sequenzen, die selektiv exprimiert sind in pre-B-Zellen und Sonden zu diesem Zweck.

Country Status (2)

Country Link
EP (1) EP0269127B1 (de)
DE (1) DE3789138T2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0867721B1 (de) * 1997-03-27 2003-03-12 Council of Scientific and Industrial Research Verfahren zur Detektion von Leukämie
EP1001020A4 (de) * 1997-07-29 2005-03-02 Sumitomo Electric Industries Gegen menschliche prä-b-zellen gerichtete antikörper
MX2009009912A (es) * 2007-03-27 2010-01-18 Sea Lane Biotechnologies Llc Constructos y colecciones que comprenden secuencias de cadena ligera sustitutas de anticuerpos.
EP2430047B1 (de) 2009-05-13 2018-03-28 i2 Pharmaceuticals, Inc. Neutralisierende moleküle gegen influenza-viren
BRPI1015916A2 (pt) 2009-06-26 2015-09-01 Sea Lane Biotechnologies Llc Molécula de ácido nucleico, vetor de expressão, célula hospedeira, bem como método para expressão de um construto de cadeia leve substituta (slc) ou de um polipeptídeo de slc
US10300140B2 (en) 2011-07-28 2019-05-28 I2 Pharmaceuticals, Inc. Sur-binding proteins against ERBB3
CA2859744A1 (en) 2011-12-22 2013-06-27 Sea Lane Biotechnologies, Llc Surrogate binding proteins
EP4177267A1 (de) 2015-02-02 2023-05-10 Children's Health Care d/b/a Children's Minnesota Leichtkettige anti-surrogate-antikörper

Also Published As

Publication number Publication date
DE3789138D1 (de) 1994-03-31
EP0269127A3 (de) 1991-03-13
EP0269127A2 (de) 1988-06-01
EP0269127B1 (de) 1994-02-23

Similar Documents

Publication Publication Date Title
DE3785901D1 (de) Festes elektrochemisches element und verfahren zu seiner herstellung.
DE69102106D1 (de) Elektrochemische Zellen enthaltender Apparat, bei dem der Reformer, die Mischdüse und der Mischverteiler integriert sind.
DE3871416D1 (de) Mischvorrichtung und verfahren zu ihrer herstellung.
DE3780993T2 (de) Elektrochemische vorrichtung.
DE3782381T2 (de) Fluessigkristall-vorrichtung und verfahren zu ihrer herstellung.
DE3850544T2 (de) Mikrosonde, deren Herstellung und elektronisches Gerät, das diese Mikrosonde gebraucht.
NO872075D0 (no) Herbicid-toleranse-kodende dna.
DE3780560D1 (de) Fuehler und verfahren zu dessen herstellung.
DE3670483D1 (de) 3-amino-4,5-dihydroxypiperidine, verfahren zu ihrer herstellung und ihre verwendung.
DE3782994T2 (de) Erythromycin-a-derivate und verfahren zu ihrer herstellung.
DE3677740D1 (de) 2-iod-perfluor-2-methylalkane, verfahren zu deren herstellung und deren verwendung.
DE3789138T2 (de) Nukleotid-Sequenzen, die selektiv exprimiert sind in pre-B-Zellen und Sonden zu diesem Zweck.
DE3870961D1 (de) Thermotrope fluessigkristalline polyester, und verfahren zu ihrer herstellung.
DE3680352D1 (de) Leitfaehigkeitsmodulations-halbleiteranordnung und verfahren zu ihrer herstellung.
DE3677812D1 (de) Polyhydroxypolyether, verfahren zu ihrer herstellung und ihre verwendung.
FI871115A (fi) Grafikapparatur baserad pao en teckengenerator.
DE3786181T2 (de) Dns-probe, spezifisch fuer das maennliche genom der wiederkaeuer, ihre herstellung und verwendung.
FI870946A0 (fi) Snabb dna-test foer paovisande av mikrober.
DE3782599D1 (de) Laser mit monolitisch integrierten, planaren elementen und verfahren zu deren herstellung.
DE3778632D1 (de) Vorrichtung zum gebrauch bei schleppnetzfischen.
DE3685209D1 (de) Urease und verfahren zu deren herstellung.
DE3768416D1 (de) Iminooxazolidine, verfahren zu ihrer herstellung und ihre verwendung.
DE3871208D1 (de) 5-oder 6-alkoxycarbonyl-2,3-dicyanonaphthaline und verfahren zu ihrer herstellung.
DE3778517D1 (de) 7-brom-beta-carbolin-derivate und verfahren zu ihrer herstellung.
DE3765291D1 (de) Polycyanoarylether, verfahren zu ihrer herstellung und ihre verwendung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee